Patton Fund Management Inc. Cuts Stake in DaVita Inc. (NYSE:DVA)

Patton Fund Management Inc. trimmed its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 22.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,348 shares of the company's stock after selling 6,336 shares during the quarter. Patton Fund Management Inc.'s holdings in DaVita were worth $3,266,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in DVA. UMB Bank n.a. boosted its stake in DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after buying an additional 76 shares during the last quarter. Copia Wealth Management purchased a new position in shares of DaVita during the 4th quarter worth $30,000. SBI Securities Co. Ltd. acquired a new position in shares of DaVita during the 4th quarter valued at about $41,000. Coppell Advisory Solutions LLC grew its holdings in shares of DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after purchasing an additional 100 shares during the period. Finally, Canada Post Corp Registered Pension Plan acquired a new stake in DaVita during the fourth quarter worth about $55,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Trading Up 0.6%

Shares of DVA stock traded up $0.87 during trading hours on Friday, hitting $136.66. The company had a trading volume of 1,711,072 shares, compared to its average volume of 825,090. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The stock has a market capitalization of $10.32 billion, a PE ratio of 13.54, a price-to-earnings-growth ratio of 0.94 and a beta of 1.11. The company's fifty day moving average is $140.22 and its 200 day moving average is $150.38. DaVita Inc. has a fifty-two week low of $131.76 and a fifty-two week high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.75 by $0.25. The company had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm's quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.26 earnings per share. Research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the stock. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. Finally, Truist Financial cut their target price on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $164.50.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.